Chiome Bioscience Inc. (JP:4583) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Chiome Bioscience Inc. reported a decline in net sales to 422 million yen for the nine months ending September 2024, with continued losses in operating and net incomes. Despite challenging financial results, the company revised its forecast for the drug discovery support business to 720 million yen, reflecting a more optimistic outlook for this segment.
For further insights into JP:4583 stock, check out TipRanks’ Stock Analysis page.